- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03466281
Patient Education for Patients With Irritable Bowel Syndrome (IBS) (IBS)
Structured Patient Group Education Versus Structured Patient Education Via the Internet for Patients With Irritable Bowel Syndrome (IBS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this randomized controlled study in patients with irritable bowel syndrome (IBS) the investigators plan to compare the effects of a structured patient group education (IBS School), which previously has been evaluated and found to efficacious for symptom improvement (1-3), with a similar education provided via the internet in a non-inferiority design. The investigators hypothesize that structured patient education provided via the internet is not inferior compared to structured patient group education.
Men and women from 18 years of age, with IBS according to the Rome III criteria, who are referred from physicians in primary care and secondary/tertiary care to receive patient education will be included. The education, both the IBS School and the internet based version, will be managed at the GI outpatient clinic at Sahlgrenska University hospital in Gothenburg. Patients with an organic GI disease and/or with another disease potentially affecting the GI symptoms are excluded. Likewise, patients with a disability to communicate in the Swedish language or to use a computer and/or do not have access to a computer or internet are excluded.
Moreover, patients with a severe psychiatric disease are excluded due to potential problems to participate in a group intervention. In order to allocate an equal number of patients to both of the interventions during the study, a number of up to 20 patients will be invited in a block and the patients will be randomly divided into two groups with an equal number of patients in each group. The groups will then be randomized 1:1 to either start the IBS School or to start the patient education via internet within two to three weeks. After the randomization all patients will receive a personal login to the database and an e-mail with information on how to log in and complete the questionnaires online. All questionnaires will be completed by the patients on-line, i.e. all data will be registered directly into the database.
The interventions:
Both interventions in the study are designed based on the self-efficacy theory, and the general theory of nursing. Moreover, the education is performed based on a biopsychosocial model considered to be important in functional GI disorders. The IBS School consists of three, two hour sessions held once per week in a group setting with eight to ten patients in each group. A nurse and a dietician lead the education and issues are chosen with the aim to cover a wide spectrum of issues related to IBS. A lot of space is given for discussion within the group. At the first session, general information is provided about IBS, symptoms, pathophysiology and treatment options. At the second session, food related issues is discussed and at the third session the effects from other life style factors like stress, physical activity and relaxation is discussed.
The patient education provided via the internet covers the same areas of issues related to IBS that are covered in the structured group education. The participants in the internet group will receive and read information which is divided into three steps, once weekly. At the end of each treatment week the patients will have a contact via the internet with the nurse and dietician and thereby receive feedback on questions that were raised during the treatment week. The patients are also encouraged to attend (anonymously) a specific, closed internet forum where they have the opportunity to discuss and reflect over information material from the last week with other patients attending the internet based intervention. The time consumed to read the information and reflect is estimated to two hours weekly.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Gothenburg, Sweden, S413-45
- Dept of Internal Medicine, Sahlgrenska University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- IBS according to the Rome III criteria
Exclusion Criteria:
- organic GI disease and/or another disease potentially affecting the GI symptoms
- severe psychiatric disease due to potential problems to participate in a group intervention
- disability to communicate in the Swedish language
- disability to use a computer or not have access to a computer or internet
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: IBS School
Patient education provided in a group setting
|
Patient education in a group setting
|
|
Active Comparator: Internet patient education
Patient education provided via the internet
|
Patient education via the internet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of GI symptoms
Time Frame: Measuring change from Baseline and up to six months after the education
|
Measured with a questionnaire; Irritable Bowel Syndrome-severity scoring system (IBS-SSS).
Five issues measure the severity of IBS symptoms on a scale, each ranging from 0 to 100.
A total score is calculated ranging from 0 to 500.
In this study the total score is used, the higher the score the worse severity of symptoms.
|
Measuring change from Baseline and up to six months after the education
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Quality of life
Time Frame: Measuring change from Baseline and up to six months after the education
|
Measured with a questionnaires; Irritable Bowel Syndrome Quality Of Life (IBSQOL) is a disease-specific HRQOL instrument, including 30 items measuring nine dimensions of health, emotional functioning, mental health, sleep, energy, physical functioning, diet, social role, physical role and sexual relations.
Raw scores are transformed into a scale of 0-100, with 100 representing the best possible quality of life scores for each of the nine dimensions.
|
Measuring change from Baseline and up to six months after the education
|
|
Change of Psychological symptoms
Time Frame: Measuring change from Baseline and up to six months after the education
|
Measured with a questionnaire; Hospital Anxiety and Depression scale (HAD).
This scale consists of 14 items with seven items relating to anxiety and seven to depression.
A four-graded scale was used (0-3), giving a total range from 0 to 21 on each subscale.
The higher the score, the more pronounced the symptom.
HAD was developed for nonpsychiatric medical patients to detect anxiety and depression.
|
Measuring change from Baseline and up to six months after the education
|
|
Change of GI specific anxiety
Time Frame: Measuring change from Baseline and up to six months after the education
|
Measured with a questionnaire; Visceral Sensitivity Index (VSI) which is a 15-item (each question ranging from 0 to 5) questionnaire designed to measure the degree of GI-specific anxiety in IBS.
The total score ranges from 0 (no GI-specific anxiety) to 75 (severe GI-specific anxiety), and the higher the score, the higher the GI-specific anxiety
|
Measuring change from Baseline and up to six months after the education
|
|
Change of Perceived knowledge about IBS
Time Frame: Measuring change from Baseline and up to six months after the education
|
Measured with a Visual Analogue scale (VAS).
The patients were asked to rate their perceived knowledge of IBS on a Visual Analog Scale (VAS).
The scale comprised a 100-mm straight line with the extremes labeled 'No knowledge at all' and 'Very much knowledge'.
The score ranges from 0 to 100 and the higher the score the more perceived knowledge of IBS.
|
Measuring change from Baseline and up to six months after the education
|
Collaborators and Investigators
Investigators
- Principal Investigator: Magnus Simren, MD, Prof, Dept of internal medicine, Gothenburg University
Publications and helpful links
General Publications
- Ringstrom G, Storsrud S, Lundqvist S, Westman B, Simren M. Development of an educational intervention for patients with Irritable Bowel Syndrome (IBS): a pilot study. BMC Gastroenterol. 2009 Feb 4;9:10. doi: 10.1186/1471-230X-9-10.
- Ringstrom G, Storsrud S, Posserud I, Lundqvist S, Westman B, Simren M. Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study. Eur J Gastroenterol Hepatol. 2010 Apr;22(4):420-8. doi: 10.1097/MEG.0b013e3283333b61.
- Ringstrom G, Storsrud S, Simren M. A comparison of a short nurse-based and a long multidisciplinary version of structured patient education in irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2012 Aug;24(8):950-7. doi: 10.1097/MEG.0b013e328354f41f.
- Lindfors P, Axelsson E, Engstrand K, Storsrud S, Jerlstad P, Tornblom H, Ljotsson B, Simren M, Ringstrom G. Online Education Is Non-Inferior to Group Education for Irritable Bowel Syndrome: A Randomized Trial and Patient Preference Trial. Clin Gastroenterol Hepatol. 2021 Apr;19(4):743-751.e1. doi: 10.1016/j.cgh.2020.04.005. Epub 2020 Apr 11.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IBS patient education
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on IBS - Irritable Bowel Syndrome
-
Dr Anthony HobsonCompletedIrritable Bowel Syndrome (IBS) | Irritable Bowel Syndrome With Diarrhea (IBS-D)United Kingdom
-
Devintec SaglRecruitingIrritable Bowel Syndrome (IBS) | Irritable Bowel Syndrome of Diarrhea Type (IBS-D)Italy, Spain, France, Belgium
-
Guy BoeckxstaensFund for Scientific Research, Flanders, BelgiumRecruiting
-
Kyle Staller, MD, MPHArdelyxCompletedIBS - Irritable Bowel Syndrome | IBSUnited States
-
Iuliu Hatieganu University of Medicine and PharmacyNot yet recruitingIrritable Bowel Syndrome (IBS)Romania
-
Taipei Veterans General Hospital, TaiwanNot yet recruitingIBS - Irritable Bowel SyndromeTaiwan
-
Sahlgrenska University HospitalRecruitingIrritable Bowel Syndrome (IBS)Sweden
-
PGP HealthRecruitingA Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel SyndromeIBS (Irritable Bowel Syndrome)United States
-
University of RijekaRecruitingIrritable Bowel Syndrome (IBS)Croatia
-
Children's Hospital of PhiladelphiaRecruiting
Clinical Trials on Structured patient group education
-
University of MalayaCompletedPressure Injury | Limitation, MobilityMalaysia
-
Gottsegen National Cardiovascular InstituteRecruiting
-
University of MalayaRecruiting
-
Aga Khan University Hospital, PakistanRecruitingAnxiety | SatisfactionPakistan
-
Ataturk UniversityCompletedEffects of Post-Thyroidectomy Head and Neck Stretching Exercises on Voice, Anxiety, and Psychological ResilienceTurkey (Türkiye)
-
Chinese University of Hong KongThe Hong Kong Polytechnic UniversityUnknown
-
Azienda Ospedaliero-Universitaria CareggiTerminatedDiabetes Mellitus, Type 1
-
Kutahya Health Sciences UniversityCompleted
-
Ataturk UniversityCompleted
-
Columbia UniversityNew York City Council Speaker's FundCompleted